← Leaderboards
Krishna Chaitanya Mudumbi
Yale University
$442,756
Attributed
$442,756
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$442,756 · 2
By mechanism
R00$249,000 · 1
K99$193,756 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Mark A. Lemmon$27,011,161
- Robert T Malison$17,226,399
- Michael Simons$49,269,368
- John Pierce Wise$13,123,215
- Adeeba Kamarulzaman$2,540,928
Others in their field
Other Emerging Leaders on “Epigen”
- Hudson Santos · Univ Of North Carolina Chapel Hill$5,524,209
- Kevin Jon Cheung · Fred Hutchinson Cancer Center$2,387,419
- George Thomas Eisenhoffer · University Of Tx Md Anderson Can Ctr$1,263,600
- Kevin Ron Nash · University Of South Florida$1,245,931
- Francois Haddad · Stanford University$451,538
- Anne Kristina Bozack · Columbia University Health Sciences$251,694
Research focus
EpigenAffinityEpidermal Growth FactorEpidermal Growth Factor ReceptorAreaAwardAdaptor Signaling ProteinBetacellulinEnvironmentBiochemicalBiophysicsCancer BiologyCancer CellCareerAffectCell ProliferationCellsCell SurfaceAmphiregulinDesignDimerDimerizationDrug DevelopmentEpiregulin
Grant awards (3)
Understanding biased agonism in receptor tyrosine kinases to devise new modalities for their targeting in cancer$249,000
R00 · FY2025 · CA · contact PI
Understanding biased agonism in receptor tyrosine kinases to devise new modalities for their targeting in cancer$95,994
K99 · FY2022 · CA · contact PI
Understanding biased agonism in receptor tyrosine kinases to devise new modalities for their targeting in cancer$97,762
K99 · FY2021 · CA · contact PI